Ibrom Eye Drop contains Bromfenac 0.09% w/v, a nonsteroidal anti-inflammatory drug (NSAID) specifically formulated for ophthalmic use. Bromfenac acts by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the synthesis of prostaglandins responsible for inflammation, pain, and edema in ocular tissues. Ibrom Eye Drop is primarily indicated for the treatment of postoperative inflammation and prevention of ocular pain following cataract surgery. It is also utilized in managing other inflammatory conditions of the eye where NSAID therapy is appropriate. The formulation ensures rapid penetration into ocular tissues, providing effective anti-inflammatory and analgesic effects with minimal systemic absorption. Ibrom Eye Drop should be administered as directed by a healthcare professional, typically one drop into the affected eye(s) twice daily, starting 24 hours before surgery and continuing for up to two weeks postoperatively. Caution is advised in patients with known hypersensitivity to bromfenac or other NSAIDs. Use with care in individuals with pre-existing ocular conditions such as dry eye or corneal epithelial defects. Common adverse effects may include transient burning or stinging upon instillation, blurred vision, or ocular irritation. Patients should avoid contact lens use during treatment unless otherwise advised by their physician.